Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 103843
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103843
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.103843
Table 1 Molecular functions of NOS1 gene
GO ID | Qualified GO term | Evidence |
0004517 | Nitric-oxide synthase activity | IDA, ISS, IBA, TAS |
0005246 | Calcium channel regulator activity | TAS |
0005515 | Protein binding | IPI |
0005516 | Calmodulin binding | IEA |
0010181 | Flavin mononucleotide binding | ISS, IBA |
0016491 | Oxidoreductase activity | IEA |
0017080 | Sodium channel regulator activity | ISS |
0020037 | Heme binding | ISS |
0034617 | Tetrahydrobiopterin binding | NAS |
0034618 | Arginine binding | TAS |
0044325 | Transmembrane transporter binding | ISS, TAS |
0046870 | Cadmium ion binding | ISS |
0046872 | Metal ion binding | IEA |
0048306 | Calcium-dependent protein binding | ISS |
0050660 | Flavin adenine dinucleotide binding | ISS, IBA |
0050661 | NADP binding | ISS |
0097110 | Scaffold protein binding | ISS |
- Citation: Xiao ZW, Zeng YC, Ji LT, Yuan JT, Li L. Nitric oxide synthase 1 inhibits the progression of esophageal cancer through interacting with nitric oxide synthase 1 adaptor protein. World J Gastrointest Oncol 2025; 17(4): 103843
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/103843.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.103843